1 Introduction to Research & Analysis Reports
    1.1 Immune Globulins Market Definition
    1.2 Market Segments
        1.2.1 Market by Type
        1.2.2 Market by Application
    1.3 Global Immune Globulins Market Overview
    1.4 Features & Benefits of This Report
    1.5 Methodology & Sources of Information
        1.5.1 Research Methodology
        1.5.2 Research Process
        1.5.3 Base Year
        1.5.4 Report Assumptions & Caveats
2 Global Immune Globulins Overall Market Size
    2.1 Global Immune Globulins Market Size: 2021 VS 2027
    2.2 Global Immune Globulins Revenue, Prospects & Forecasts: 2016-2027
    2.3 Global Immune Globulins Sales (Consumption): 2016-2027
3 Company Landscape
    3.1 Top Immune Globulins Players in Global Market
    3.2 Top Global Immune Globulins Companies Ranked by Revenue
    3.3 Global Immune Globulins Revenue by Companies
    3.4 Global Immune Globulins Sales by Companies
    3.5 Global Immune Globulins Price by Manufacturer (2016-2021)
    3.6 Top 3 and Top 5 Immune Globulins Companies in Global Market, by Revenue in 2020
    3.7 Global Manufacturers Immune Globulins Product Type
    3.8 Tier 1, Tier 2 and Tier 3 Immune Globulins Players in Global Market
        3.8.1 List of Global Tier 1 Immune Globulins Companies
        3.8.2 List of Global Tier 2 and Tier 3 Immune Globulins Companies
4 Sights by Product
    4.1 Overview
        4.1.1 By Type - Global Immune Globulins Market Size Markets, 2021 & 2027
        4.1.2 IVIg Liquid
        4.1.3 IVIg Powder
    4.2 By Type - Global Immune Globulins Revenue & Forecasts
        4.2.1 By Type - Global Immune Globulins Revenue, 2016-2021
        4.2.2 By Type - Global Immune Globulins Revenue, 2022-2027
        4.2.3 By Type - Global Immune Globulins Revenue Market Share, 2016-2027
    4.3 By Type - Global Immune Globulins Sales & Forecasts
        4.3.1 By Type - Global Immune Globulins Sales, 2016-2021
        4.3.2 By Type - Global Immune Globulins Sales, 2022-2027
        4.3.3 By Type - Global Immune Globulins Sales Market Share, 2016-2027
    4.4 By Type - Global Immune Globulins Price (Manufacturers Selling Prices), 2016-2027
5 Sights by Application
    5.1 Overview
        5.1.1 By Application - Global Immune Globulins Market Size, 2021 & 2027
        5.1.2 Immunodeficiency
        5.1.3 Autoimmune Disease
        5.1.4 Acute Infection
    5.2 By Application - Global Immune Globulins Revenue & Forecasts
        5.2.1 By Application - Global Immune Globulins Revenue, 2016-2021
        5.2.2 By Application - Global Immune Globulins Revenue, 2022-2027
        5.2.3 By Application - Global Immune Globulins Revenue Market Share, 2016-2027
    5.3 By Application - Global Immune Globulins Sales & Forecasts
        5.3.1 By Application - Global Immune Globulins Sales, 2016-2021
        5.3.2 By Application - Global Immune Globulins Sales, 2022-2027
        5.3.3 By Application - Global Immune Globulins Sales Market Share, 2016-2027
    5.4 By Application - Global Immune Globulins Price (Manufacturers Selling Prices), 2016-2027
6 Sights by Region
    6.1 By Region - Global Immune Globulins Market Size, 2021 & 2027
    6.2 By Region - Global Immune Globulins Revenue & Forecasts
        6.2.1 By Region - Global Immune Globulins Revenue, 2016-2021
        6.2.2 By Region - Global Immune Globulins Revenue, 2022-2027
        6.2.3 By Region - Global Immune Globulins Revenue Market Share, 2016-2027
    6.3 By Region - Global Immune Globulins Sales & Forecasts
        6.3.1 By Region - Global Immune Globulins Sales, 2016-2021
        6.3.2 By Region - Global Immune Globulins Sales, 2022-2027
        6.3.3 By Region - Global Immune Globulins Sales Market Share, 2016-2027
    6.4 North America
        6.4.1 By Country - North America Immune Globulins Revenue, 2016-2027
        6.4.2 By Country - North America Immune Globulins Sales, 2016-2027
        6.4.3 US Immune Globulins Market Size, 2016-2027
        6.4.4 Canada Immune Globulins Market Size, 2016-2027
        6.4.5 Mexico Immune Globulins Market Size, 2016-2027
    6.5 Europe
        6.5.1 By Country - Europe Immune Globulins Revenue, 2016-2027
        6.5.2 By Country - Europe Immune Globulins Sales, 2016-2027
        6.5.3 Germany Immune Globulins Market Size, 2016-2027
        6.5.4 France Immune Globulins Market Size, 2016-2027
        6.5.5 U.K. Immune Globulins Market Size, 2016-2027
        6.5.6 Italy Immune Globulins Market Size, 2016-2027
        6.5.7 Russia Immune Globulins Market Size, 2016-2027
        6.5.8 Nordic Countries Immune Globulins Market Size, 2016-2027
        6.5.9 Benelux Immune Globulins Market Size, 2016-2027
    6.6 Asia
        6.6.1 By Region - Asia Immune Globulins Revenue, 2016-2027
        6.6.2 By Region - Asia Immune Globulins Sales, 2016-2027
        6.6.3 China Immune Globulins Market Size, 2016-2027
        6.6.4 Japan Immune Globulins Market Size, 2016-2027
        6.6.5 South Korea Immune Globulins Market Size, 2016-2027
        6.6.6 Southeast Asia Immune Globulins Market Size, 2016-2027
        6.6.7 India Immune Globulins Market Size, 2016-2027
    6.7 South America
        6.7.1 By Country - South America Immune Globulins Revenue, 2016-2027
        6.7.2 By Country - South America Immune Globulins Sales, 2016-2027
        6.7.3 Brazil Immune Globulins Market Size, 2016-2027
        6.7.4 Argentina Immune Globulins Market Size, 2016-2027
    6.8 Middle East & Africa
        6.8.1 By Country - Middle East & Africa Immune Globulins Revenue, 2016-2027
        6.8.2 By Country - Middle East & Africa Immune Globulins Sales, 2016-2027
        6.8.3 Turkey Immune Globulins Market Size, 2016-2027
        6.8.4 Israel Immune Globulins Market Size, 2016-2027
        6.8.5 Saudi Arabia Immune Globulins Market Size, 2016-2027
        6.8.6 UAE Immune Globulins Market Size, 2016-2027
7 Manufacturers & Brands Profiles
    7.1 Takeda
        7.1.1 Takeda Corporate Summary
        7.1.2 Takeda Business Overview
        7.1.3 Takeda Immune Globulins Major Product Offerings
        7.1.4 Takeda Immune Globulins Sales and Revenue in Global (2016-2021)
        7.1.5 Takeda Key News
    7.2 Grifols
        7.2.1 Grifols Corporate Summary
        7.2.2 Grifols Business Overview
        7.2.3 Grifols Immune Globulins Major Product Offerings
        7.2.4 Grifols Immune Globulins Sales and Revenue in Global (2016-2021)
        7.2.5 Grifols Key News
    7.3 CSL
        7.3.1 CSL Corporate Summary
        7.3.2 CSL Business Overview
        7.3.3 CSL Immune Globulins Major Product Offerings
        7.3.4 CSL Immune Globulins Sales and Revenue in Global (2016-2021)
        7.3.5 CSL Key News
    7.4 Octapharma
        7.4.1 Octapharma Corporate Summary
        7.4.2 Octapharma Business Overview
        7.4.3 Octapharma Immune Globulins Major Product Offerings
        7.4.4 Octapharma Immune Globulins Sales and Revenue in Global (2016-2021)
        7.4.5 Octapharma Key News
    7.5 Biotest
        7.5.1 Biotest Corporate Summary
        7.5.2 Biotest Business Overview
        7.5.3 Biotest Immune Globulins Major Product Offerings
        7.5.4 Biotest Immune Globulins Sales and Revenue in Global (2016-2021)
        7.5.5 Biotest Key News
    7.6 Kedrion
        7.6.1 Kedrion Corporate Summary
        7.6.2 Kedrion Business Overview
        7.6.3 Kedrion Immune Globulins Major Product Offerings
        7.6.4 Kedrion Immune Globulins Sales and Revenue in Global (2016-2021)
        7.6.5 Kedrion Key News
    7.7 Hualan Bio
        7.7.1 Hualan Bio Corporate Summary
        7.7.2 Hualan Bio Business Overview
        7.7.3 Hualan Bio Immune Globulins Major Product Offerings
        7.4.4 Hualan Bio Immune Globulins Sales and Revenue in Global (2016-2021)
        7.7.5 Hualan Bio Key News
    7.8 CNBG
        7.8.1 CNBG Corporate Summary
        7.8.2 CNBG Business Overview
        7.8.3 CNBG Immune Globulins Major Product Offerings
        7.8.4 CNBG Immune Globulins Sales and Revenue in Global (2016-2021)
        7.8.5 CNBG Key News
    7.9 Shanghai RAAS
        7.9.1 Shanghai RAAS Corporate Summary
        7.9.2 Shanghai RAAS Business Overview
        7.9.3 Shanghai RAAS Immune Globulins Major Product Offerings
        7.9.4 Shanghai RAAS Immune Globulins Sales and Revenue in Global (2016-2021)
        7.9.5 Shanghai RAAS Key News
    7.10 CBPO
        7.10.1 CBPO Corporate Summary
        7.10.2 CBPO Business Overview
        7.10.3 CBPO Immune Globulins Major Product Offerings
        7.10.4 CBPO Immune Globulins Sales and Revenue in Global (2016-2021)
        7.10.5 CBPO Key News
    7.11 LFB Group
        7.11.1 LFB Group Corporate Summary
        7.11.2 LFB Group Immune Globulins Business Overview
        7.11.3 LFB Group Immune Globulins Major Product Offerings
        7.11.4 LFB Group Immune Globulins Sales and Revenue in Global (2016-2021)
        7.11.5 LFB Group Key News
    7.12 BPL
        7.12.1 BPL Corporate Summary
        7.12.2 BPL Immune Globulins Business Overview
        7.12.3 BPL Immune Globulins Major Product Offerings
        7.12.4 BPL Immune Globulins Sales and Revenue in Global (2016-2021)
        7.12.5 BPL Key News
    7.13 Sichuan Yuanda Shuyang
        7.13.1 Sichuan Yuanda Shuyang Corporate Summary
        7.13.2 Sichuan Yuanda Shuyang Immune Globulins Business Overview
        7.13.3 Sichuan Yuanda Shuyang Immune Globulins Major Product Offerings
        7.13.4 Sichuan Yuanda Shuyang Immune Globulins Sales and Revenue in Global (2016-2021)
        7.13.5 Sichuan Yuanda Shuyang Key News
8 Global Immune Globulins Production Capacity, Analysis
    8.1 Global Immune Globulins Production Capacity, 2016-2027
    8.2 Immune Globulins Production Capacity of Key Manufacturers in Global Market
    8.3 Global Immune Globulins Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
    9.1 Market Opportunities & Trends
    9.2 Market Drivers
    9.3 Market Restraints
10 Immune Globulins Supply Chain Analysis
    10.1 Immune Globulins Industry Value Chain
    10.2 Immune Globulins Upstream Market
    10.3 Immune Globulins Downstream and Clients
    10.4 Marketing Channels Analysis
        10.4.1 Marketing Channels
        10.4.2 Immune Globulins Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
    12.1 Note
    12.2 Examples of Clients
    12.3 Disclaimer